BAM
BMY icon

Belpointe Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$3.35M Sell
72,415
-24,163
-25% -$1.12M 0.14% 128
2025
Q1
$5.89M Sell
96,578
-91,863
-49% -$5.6M 0.31% 58
2024
Q4
$9.41M Sell
188,441
-6,943
-4% -$347K 0.57% 26
2024
Q3
$10.1M Buy
195,384
+5,955
+3% +$308K 0.61% 23
2024
Q2
$7.87M Buy
189,429
+6,004
+3% +$249K 0.55% 27
2024
Q1
$9.95M Buy
183,425
+24,803
+16% +$1.35M 0.75% 19
2023
Q4
$8.14M Sell
158,622
-3,335
-2% -$171K 0.71% 22
2023
Q3
$9.4M Sell
161,957
-267
-0.2% -$15.5K 0.97% 16
2023
Q2
$10.4M Buy
162,224
+6,906
+4% +$442K 1.1% 14
2023
Q1
$10.8M Buy
155,318
+5,030
+3% +$349K 0.58% 24
2022
Q4
$10.8M Buy
150,288
+956
+0.6% +$68.8K 0.65% 18
2022
Q3
$10.6M Buy
149,332
+2,290
+2% +$163K 0.72% 18
2022
Q2
$11.3M Sell
147,042
-19,607
-12% -$1.51M 0.76% 17
2022
Q1
$12.2M Buy
166,649
+10,519
+7% +$768K 0.74% 19
2021
Q4
$9.74M Sell
156,130
-1,325
-0.8% -$82.6K 0.61% 23
2021
Q3
$9.32M Buy
157,455
+3,232
+2% +$191K 0.64% 19
2021
Q2
$10.3M Sell
154,223
-88,637
-36% -$5.92M 0.74% 19
2021
Q1
$15.3M Buy
242,860
+31,593
+15% +$1.99M 1.31% 9
2020
Q4
$13.1M Buy
211,267
+18,133
+9% +$1.12M 1.18% 10
2020
Q3
$11.6M Buy
193,134
+1,439
+0.8% +$86.7K 1.3% 11
2020
Q2
$11.3M Buy
191,695
+2,567
+1% +$151K 1.46% 10
2020
Q1
$10.5M Buy
189,128
+15,814
+9% +$882K 1.85% 6
2019
Q4
$11.1M Buy
173,314
+11,325
+7% +$727K 1.41% 7
2019
Q3
$8.21M Sell
161,989
-423
-0.3% -$21.4K 1.33% 7
2019
Q2
$7.37M Sell
162,412
-4,614
-3% -$209K 1.45% 8
2019
Q1
$7.97M Sell
167,026
-147
-0.1% -$7.01K 1.56% 12
2018
Q4
$8.69M Sell
167,173
-4,425
-3% -$230K 2.2% 4
2018
Q3
$10.7M Buy
171,598
+11,766
+7% +$730K 1.68% 7
2018
Q2
$8.85M Buy
159,832
+538
+0.3% +$29.8K 2.47% 3
2018
Q1
$10.1M Sell
159,294
-3,438
-2% -$217K 2.94% 3
2017
Q4
$9.97M Sell
162,732
-1,154
-0.7% -$70.7K 2.18% 4
2017
Q3
$10.4M Buy
+163,886
New +$10.4M 2.44% 4